DexCom
DXCM
213 hedge funds and large institutions have $2.9B invested in DexCom in 2014 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 59 increasing their positions, 98 reducing their positions, and 18 closing their positions.
83% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 18
17% more capital invested
Capital invested by funds: $2.47B → $2.9B (+$428M)
6% more funds holding
Funds holding: 201 → 213 (+12)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
40% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 98
70% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $4.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$108M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$106M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$52.8M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$24.3M |
| 5 |
CCI
Columbus Circle Investors
|
+$22.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$63.5M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$57.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$21.1M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$21.1M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$17.2M |
DXCM Hedge Fund Activity: Q1 2014 in Review
213 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2014, worth a combined $2.9B — up 17% from $2.47B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new DXCM positions and 18 closed out — a net gain of 15 holders — while 59 added to existing stakes and 98 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $108M. The largest seller was Frontier Capital Management, cutting an estimated $63.5M.
- 213 institutional investors held DexCom (DXCM) as of Q1 2014, up from 201 in Q4 2013.
- Funds reported $2.9B of DexCom stock for Q1 2014, up 17% quarter-over-quarter.
- 33 funds opened new DexCom positions in Q1 2014 and 18 closed out, a net change of +15 holders.
- The largest DexCom buyer in Q1 2014 was T. Rowe Price Associates, an estimated $108M added.
- The largest DexCom seller in Q1 2014 was Frontier Capital Management, an estimated $63.5M sold.
Based on aggregated 13F filings for Q1 2014.